Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats

Gastroenterology

Volumn 146, Issue 2, 2014, Pages

  Xu, Dabo ^a   Gao, Jun ^a   Gillilland III, Merritt ^a   Wu, Xiaoyin ^a   Song, Il ^a   Kao, John Y ^a   Owyang, Chung ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Antibiotic; Gut Flora; Intestine; Irritable Bowel Syndrome

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; NEOMYCIN; OCCLUDIN; RIFAXIMIN; RNA 16S; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; CHRONIC STRESS; CONTROLLED STUDY; ENTERITIS; IMMOBILIZATION STRESS; IMMUNOBLOTTING; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS; MALE; MICROBIAL COMMUNITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; RAT; REVERSE TRANSCRIPTION; VISCERAL PAIN;

ANTIBIOTIC; COLORECTAL DISTENTION; CRD; ELECTROMYOGRAPHIC; EMG; GUT FLORA; IBS; IFN-GAMMA; IL; INTERFERON-GAMMA; INTERLEUKIN; INTESTINE; IRRITABLE BOWEL SYNDROME; PCR; POLYMERASE CHAIN REACTION; PREGNANE X RECEPTOR; PXR; RF; RIBOSOMAL RNA; RIFAXIMIN; RRNA; TNF-Α; TUMOR NECROSIS FACTOR-Α; VISCEROMOTOR RESPONSE; VMR; WAS; WATER AVOIDANCE STRESS;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CYTOKINES; DNA, BACTERIAL; DRUG ADMINISTRATION SCHEDULE; GASTROINTESTINAL AGENTS; HYPERALGESIA; ILEITIS; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MICROBIOTA; NEOMYCIN; OCCLUDIN; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIFAMYCINS; SEQUENCE ANALYSIS, DNA; STRESS, PSYCHOLOGICAL;

EID: 84892825869     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.10.026     Document Type: Article

References (49)

1. M. Pimentel, A. Lembo, and W.D. Chey et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation N Engl J Med 364 2011 22 32
2. S.B. Menees, M. Maneerattannaporn, and H.M. Kim et al. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis Am J Gastroenterol 107 2012 28 35 quiz 36
3. M. Pimentel, S. Park, and J. Mirocha et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial Ann Intern Med 145 2006 557 563
4. A.C. Ford, and N.J. Talley Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review J Gastroenterol 46 2011 421 431
5. S.P. Dunlop, J. Hebden, and E. Campbell et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes Am J Gastroenterol 101 2006 1288 1294
6. Q. Zhou, B. Zhang, and G.N. Verne Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome Pain 146 2009 41 46
7. T. Piche, G. Barbara, and P. Aubert et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators Gut 58 2009 196 201
8. E.C. Lauritano, V. Valenza, and L. Sparano et al. Small intestinal bacterial overgrowth and intestinal permeability Scand J Gastroenterol 45 2010 1131 1132
9. M. Camilleri, K. Madsen, and R. Spiller et al. Intestinal barrier function in health and gastrointestinal disease Neurogastroenterol Motil 24 2012 503 512
10. J.K. Marshall, M. Thabane, and A.X. Garg et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario Aliment Pharmacol Ther 20 2004 1317 1322
11. S. Nobaek, M.L. Johansson, and G. Molin et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome Am J Gastroenterol 95 2000 1231 1238
12. E.J. Bennett, C.C. Tennant, and C. Piesse et al. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome Gut 1998 256 261
13. K.A. Gwee, Y.L. Leong, and C. Graham et al. The role of psychological and biological factors in postinfective gut dysfunction Gut 44 1999 400 406
14. I.J. Elenkov, and G.P. Chrousos Stress system - organization, physiology and immunoregulation Neuroimmunomodulation 13 2006 257 267
15. S.V. Coutinho, P.M. Plotsky, and M. Sablad et al. Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat Am J Physiol Gastrointest Liver Physiol 282 2002 G307 G316
16. S. Bradesi, I. Schwetz, and H.S. Ennes et al. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia Am J Physiol Gastrointest Liver Physiol 289 2005 G42 G53
17. H. Eutamene, F. Lamine, and C. Chabo et al. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats J Nutr 137 2007 1901 1907
18. S.M. O'Mahony, J.R. Marchesi, and P. Scully et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses Biol Psychiatry 65 2009 263 267
19. M.T. Bailey, S.E. Dowd, and N.M. Parry et al. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium Infect Immunity 78 2010 1509 1519
20. C. Scarpignato, and I. Pelosini Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic Digestion 73 Suppl 1 2006 13 27
21. C.D. Jahraus, B. Schemera, and P. Rynders et al. Rifaximin diminishes neutropenia following potentially lethal whole-body radiation Exp Biol Med (Maywood) 235 2010 900 905
22. D. Zelena, Z. Mergl, and A. Foldes et al. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint Am J Physiol Endocrin Metab 285 2003 E1110 E1117
23. P.D. Schloss, S.L. Westcott, and T. Ryabin et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities Appl Environ Microbiol 75 2009 7537 7541
24. Q. Wang, C.H. Fang, and P.O. Hasselgren Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice Am J Physiol Regul Integr Comp Physiol 281 2001 R1013 R1023
25. P. Brun, I. Castagliuolo, and V. Di Leo et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis Am J Physiol Gastrointest Liver Physiol 292 2007 G518 G525
26. A. Ait-Belgnaoui, S. Bradesi, and J. Fioramonti et al. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase Pain 113 2005 141 147
27. G. Grabauskas, D. Xu, and X. Wu et al. HCN2 ion channel in dorsal root ganglion neurons is responsible for visceral hypersensitivity in chronically stressed rat Gastroenterology 142 Suppl 1 2012 A 238
28. 2 which activates HCN2 ion channel in dorsal root ganglia mediates visceral hypersensitivity in chronically stressed rats Gastroenterology 144 Suppl 1 2013 S-133 S-134
29. M.T. Bailey, S.E. Dowd, and J.D. Galley et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation Brain Behav Immunity 25 2011 397 407
30. L.V. Hooper, M.H. Wong, and A. Thelin et al. Molecular analysis of commensal host-microbial relationships in the intestine Science 291 2001 881 884
31. M. Rajilic-Stojanovic, E. Biagi, and H.G. Heilig et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome Gastroenterology 141 2011 1792 1801
32. E. Malinen, T. Rinttila, and K. Kajander et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR Am J Gastroenterol 100 2005 373 382
33. A. Kassinen, L. Krogius-Kurikka, and H. Makivuokko et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects Gastroenterology 133 2007 24 33
34. I.B. Jeffery, P.W. O'Toole, and L. Ohman et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota Gut 61 2012 997 1006
35. S.M. Collins, and P. Bercik The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease Gastroenterology 136 2009 2003 2014
36. M. Zareie, K. Johnson-Henry, and J. Jury et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress Gut 55 2006 1553 1560
37. N. Borruel, M. Carol, and F. Casellas et al. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria Gut 51 2002 659 664
38. M. Llopis, M. Antolin, and M. Carol et al. Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa Inflamm Bowel Dis 15 2009 275 283
39. E.F. Verdú, P. Bercik, and M. Verma-Gandhu et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice Gut 55 2006 182 190
40. A. Mencarelli, B. Renga, and G. Palladino et al. Inhibition of NF-Κβ by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells Eur J Pharmacol 668 2011 317 324
41. S.A. Jones, L.B. Moore, and J.L. Shenk et al. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution Mol Endocrinol 14 2000 27 39
42. A.I. Sharara, E. Aoun, and H. Abdul-Baki et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence Am J Gastroenterol 101 2006 326 333
43. A. Lembo, S.F. Zakko, and N.L. Ferreira et al. Rifaximin for the treatment of diarrhea-associated irritable bowel syndrome: short-term treatment leading to long-term sustained response Gastroenterology 134 Suppl 1 2008 A-545 (abstract T1390)
44. A. Tsiotsias, C. Voidarou, and J. Skoufos et al. Stress-induced alterations in intestinal microflora Microb Ecol Health Dis 16 2004 28 31
45. D. Zelena, Z. Mergl, and A. Foldes et al. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint Am J Physiol Endocrinol Metab 285 2003 E1110 E1117
46. P.D. Schloss, S.L. Westcott, and T. Ryabin et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities Appl Environ Microbiol 75 2009 7537 7541
47. E.A. Mayer The neurobiology of stress and gastrointestinal disease Gut 47 2000 861 869
48. S.V. Coutinho, P.M. Plotsky, and M. Sablad et al. Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat Am J Physiol Gastrointest Liver Physiol 282 2002 G307 G316
49. S. Bradesi, I. Schwetz, and H.S. Ennes et al. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia Am J Physiol Gastrointest Liver Physiol 289 2005 G42 G53